|
AVL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.470200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.591800E-01 |
| Normal-vs-Stage2 |
4.166000E-01 |
| Normal-vs-Stage3 |
8.336000E-01 |
| Normal-vs-Stage4 |
2.466800E-01 |
| Stage1-vs-Stage2 |
4.212600E-01 |
| Stage1-vs-Stage3 |
9.324200E-01 |
| Stage1-vs-Stage4 |
4.830800E-01 |
| Stage2-vs-Stage3 |
5.339600E-01 |
| Stage2-vs-Stage4 |
1.876650E-01 |
| Stage3-vs-Stage4 |
4.127600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.718800E-01 |
| Normal-vs-AfricanAmerican |
2.947600E-01 |
| Normal-vs-Asian |
4.070400E-01 |
| Caucasian-vs-AfricanAmerican |
3.965600E-02 |
| Caucasian-vs-Asian |
5.083800E-01 |
| AfricanAmerican-vs-Asian |
8.908800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.707800E-01 |
| Normal-vs-Female |
4.993900E-02 |
| Male-vs-Female |
5.246000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.079800E-01 |
| Normal-vs-Extreme_Weight |
3.969000E-01 |
| Normal-vs-Obese |
2.001200E-01 |
| Normal-vs-Extreme_Obese |
8.197200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.991200E-01 |
| Normal_Weight-vs-Obese |
2.355000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.317400E-01 |
| Extreme_Weight-vs-Obese |
6.196100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.445800E-01 |
| Obese-vs-Extreme_Obese |
7.366200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.289800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.316040E-01 |
| Normal-vs-Age(61-80Yrs) |
9.200400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.092000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.270200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.791800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.177200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.114050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.888210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.619400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.157800E-01 |
| Normal-VS-Type2 PRCC |
7.056600E-01 |
| Normal-VS-KIRP CIMP |
2.768800E-01 |
| Normal-VS-Unclassified PRCC |
8.809600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.544400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.905800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.094410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.201400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.548840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.071800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.313800E-01 |
| Normal-vs-N1 |
4.822600E-01 |
| Normal-vs-N2 |
4.493200E-01 |
| N0-vs-N1 |
2.131400E-01 |
| N0-vs-N2 |
4.790600E-01 |
| N1-vs-N2 |
8.853000E-01 |
|
|
